Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    • News

  • March 2025 quarter CPI above expectations – but RBA cut still likely
    March 2025 quarter CPI above expectations – but RBA cut still likely
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

  • Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    • News

  • Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    • News

  • Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    • News

  • Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    • News

  • Spenda Secures $3M Term Loan to Accelerate Growth
    Spenda Secures $3M Term Loan to Accelerate Growth
    • News

HeraMED Teams Up with Garmin to Transform Pregnancy Monitoring

  • In News
  • February 25, 2025
  • Gracen Moore
HeraMED Teams Up with Garmin to Transform Pregnancy Monitoring

Expanding Digital Maternity Care with Wearable Technology

HeraMED (ASX:HMD), a leader in digital maternity care, has secured a strategic collaboration with global smartwatch giant Garmin (NYSE:GRMN). The agreement enables seamless integration of Garmin’s smartwatch data into HeraMED’s remote pregnancy monitoring platform, HeraCARE—offering expectant mothers and healthcare providers a more comprehensive view of maternal health.

HeraMED CEO Anoushka Gungadin is confident about the impact of the partnership. “This is an incredibly exciting collaboration for HeraMED. Garmin is a globally recognised brand that has developed a specific smartwatch technology strategy for women. It is a significant step forward in our mission to revolutionise maternity care.”

Enhancing Health Data Access for Expectant Mothers

Through Garmin Health’s Application Programming Interface (API), users who consent to data sharing will be able to integrate key health metrics—including heart rate, sleep patterns, and fitness activity levels—into the HeraCARE platform.

“This collaboration is about bringing health and wellness data into our clinical-grade platform,” Gungadin said. “The additional data points will contribute to HeraMED’s ‘data-as-an-asset’ approach, with the potential to monitor steps for pregnant mothers with hypertensive or diabetic conditions and assess sleep quality for mental health care plans.”

The integration is expected to significantly enhance HeraCARE’s existing capabilities, which already include foetal and maternal heart rate monitoring, blood pressure tracking, and mood assessment.

Joint Marketing and Research Opportunities

Beyond data integration, HeraMED and Garmin will collaborate on marketing efforts to promote their combined digital health solutions. Additionally, the companies will explore research opportunities in women’s health, with a focus on maternity care.

“This strategic relationship will highlight how Garmin wearable data can extend beyond informing daily healthy habits to supporting pregnancy monitoring,” said Garmin Health’s Senior Director of Global B2B Sales, Joern Watzke. “By making smartwatch technology and advanced health data available for healthcare applications, we believe Garmin is truly helping change the future of women’s healthcare for the better.”

The partnership will initially run for three years, with either company able to withdraw with three months’ notice.

Long-Term Value

While the collaboration does not involve direct financial transactions, HeraMED sees significant value in the partnership. The expanded data integration is expected to strengthen HeraCARE’s market position, improve patient outcomes, and support the company’s long-term ‘data-as-an-asset’ strategy.

“This collaboration is about enriching our platform and enhancing the care experience for expectant mothers,” Gungadin said. “By leveraging Garmin’s sensor technology, we’re providing more real-time insights that empower both mothers and healthcare professionals.”

HeraMED’s latest move reinforces its commitment to digital health innovation, positioning the company at the forefront of the growing telehealth and maternity care sector.

  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path - May 6, 2025
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program - May 1, 2025
  • March 2025 quarter CPI above expectations – but RBA cut still likely - April 30, 2025
  •  
  •  
  •  
  •  
  • ASX:HMD
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    February 25, 2025, 5:58 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/pregnancy-monitoring-platform

    Reply
  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path - May 6, 2025
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program - May 1, 2025
  • March 2025 quarter CPI above expectations – but RBA cut still likely - April 30, 2025

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path - May 6, 2025
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program - May 1, 2025
  • March 2025 quarter CPI above expectations – but RBA cut still likely - April 30, 2025
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.